T2 Biosystems, Inc.
TTOO
$0.1255
-$0.006-4.56%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 34.41% | -41.22% | 24.66% | -2.39% | 11.22% |
| Total Depreciation and Amortization | -77.48% | -76.78% | -75.00% | -70.98% | 0.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -93.00% | 93.28% | -49.97% | 20.23% | 109.19% |
| Change in Net Operating Assets | 216.27% | -32.61% | 11.49% | 67.85% | -181.26% |
| Cash from Operations | 53.32% | 25.40% | 9.71% | 8.84% | 15.78% |
| Capital Expenditure | -- | -- | -- | 27.78% | 89.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 27.78% | 89.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -81.16% | -60.41% | -81.41% | -24.68% | -5.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -81.11% | -60.41% | -81.41% | 8.56% | -6.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -126.27% | -132.88% | -682.26% | 10.26% | 15.11% |
